アルツハイマー治療の世界市場分析:薬の種類別(コリンエステラーゼ阻害剤、NMDA [N-メチル-D-アスパルテート]受容体拮抗薬)、セグメント予測 -2024...市場調査レポートについてご紹介

【英文タイトル】Alzheimer’s Therapeutics Market Analysis by Drug Class (Cholinesterase Inhibitors, NMDA [N-methyl-D-aspartate] Receptor Antagonist) and Segment Forecasts to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Industry Outlook
3.1 Market Segmentation & Scope
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.1.1 Increasing prevalence of Alzheimer’s disease
3.2.1.2 Introduction of new and innovative technologies and drugs
3.2.1.3 Increased government funding
3.2.1.4 Awareness programs
3.2.2 Market restraint analysis
3.2.3 Alzheimer’s therapeutics market – Key market restraint analysis
3.2.3.1 Presence of stringent regulatory framework and long approval time for Alzheimer’s therapeutics
3.2.4 Alzheimer’s therapeutics Market dynamics
3.2.5 Key opportunities prioritized
3.2.6 Industry analysis – Porter’s
3.2.7 Alzheimer’s therapeutics – PESTEL analysis
Chapter 4 Market Categorization 1: Product Estimates & Trend Analysis
4.1 Alzheimer’s therapeutics market share by drug class, 2015 & 2024
4.2 Cholinesterase inhibitors
4.2.1 Cholinesterase inhibitor market estimates, 2013 – 2024 (USD Million)
4.3 N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
4.3.1 NMDA receptor antagonist market estimates, 2013 – 2024 (USD Million)
Chapter 5 Alzheimer’s Market Categorization 2: Regional Estimates & Trend Analysis, by Product
5.1 Alzheimer’s Therapeutics Market Share by Region, 2015& 2024
5.2 North America
5.2.1 North America Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.2.2 U.S
5.2.2.1 U.S. Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.2.3 Canada
5.2.3.1 Canada Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.3 Europe
5.3.1 Europe Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.3.2 UK
5.3.2.1 UK Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.3.3 Germany
5.3.3.1 Germany Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.4.2 China
5.4.2.1 China Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.4.3 Japan
5.4.3.1 Japan Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.5 Latin America
5.5.1 Latin America Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico Alzheimer’s therapeutics market, 2013-2024 (USD Million)
5.6 MEA
5.6.1 MEA Alzheimer’s therapeutics market, 2013-2024 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Alzheimer’s therapeutics market, 2013 – 2024 (USD Million)
Chapter 6 Competitive Landscape
6.1 Pfizer, Inc.
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 Eisai Co. Ltd.
6.2.1 Company overview
6.2.2 Financial performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 Actavis + Forest Laboratories
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 Lundbeck A/S
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 AC Immune
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 Merck KGaA
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4 Strategic initiatives
6.7 Novartis AG.
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
6.8 TauRx Pharmaceuticals Ltd.
6.8.1 Company overview
6.8.2 Financial performance
6.8.3 Product benchmarking
6.8.4 Strategic initiatives


【レポート販売概要】

■ タイトル:アルツハイマー治療の世界市場分析:薬の種類別(コリンエステラーゼ阻害剤、NMDA [N-メチル-D-アスパルテート]受容体拮抗薬)、セグメント予測 -2024
■ 英文:Alzheimer’s Therapeutics Market Analysis by Drug Class (Cholinesterase Inhibitors, NMDA [N-methyl-D-aspartate] Receptor Antagonist) and Segment Forecasts to 2024
■ 発行日:2016年8月22日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707039
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。